A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...

The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without ...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation automated insulin delivery ...

The US Food and Drug Administration (FDA) has expanded the indication for Tandem Diabetes Care’s Control-IQ+ Technology to include people with type 2 diabetes (T2D). The next-generation Control-IQ+ ...

Approximately 38.4 million Americans had been diagnosed with diabetes as of 2021 — but about three times that many are in danger of developing the disease, even if they don’t know it. Nearly 98 ...

Diabetes is a common condition that affects about 38 million people in the United States, and nearly 95% of those diabetes cases are type 2 diabetes. Potential symptoms may include frequent peeing, ...